Abstract

EZEOKOLI, O T  and  POHL, C H. Opportunistic pathogenic fungal co-infections are prevalent in critically ill COVID-19 patients: Are they risk factors for disease severity?. SAMJ, S. Afr. med. j. [online]. 2020, vol.110, n.10. ISSN 2078-5135.  https://doi.org/10.7196/samj.2020.v110i11.15248.

Fungal co-infections, especially with Aspergillus and Candida species, are prevalent in hospitalised COVID-19 patients, and could influence patient outcomes and hamper treatment efforts. However, information about and elucidation of the causal relationship between fungal co-infections and COVID-19 disease outcomes or severity in patients are still lacking. Such information, if and when available, will help facilitate appropriate case management.

        · text in English     · English ( pdf )